| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $4.59B | +5.2% |
| Cost of Revenue | $3.58B | +3.4% |
| Gross Profit | $1.01B | +12.1% |
| R&D Expense | $21.3M | +8.7% |
| SG&A Expense | $365.1M | +6.7% |
| Operating Income | $640.9M | +5.3% |
| Interest Expense | $110.7M | -10.9% |
| Pre-tax Income | $522.3M | +7.4% |
| Income Tax | $103.7M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $416.7M | -42.2% |
| Accounts Receivable | $686.1M | -3.3% |
| Inventory | $1.40B | +3.7% |
| Current Assets | $2.68B | -9.0% |
| Total Assets | $5.10B | -2.5% |
| Current Liabilities | $1.01B | -16.7% |
| Long-term Debt | $1.72B | +0.2% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $614.3M | +50.9% |
| Investing Cash Flow | -$234.5M | -46.9% |
| Financing Cash Flow | -$699.9M | -168.8% |
| +0.3% |
| Net Income | $404.3M | +9.9% |
| EPS (Basic) | $2.92 | +3.5% |
| EPS (Diluted) | $2.85 | +11.8% |
| Total Liabilities |
| $3.18B |
| -2.8% |
| Stockholders' Equity | $1.80B | -2.5% |